超越泰格莎的新治療：效果真的那麼好嗎？Beyond Osimertinib: Assessing the Efficacy of Novel Treatments

新治療藥物優於泰格莎（osimertinib）嗎？這種處方藥物結合化學治療和標靶藥物，可延長無惡化存活，但對整體存活的影響仍不明確。研究正在評估其真正效果。

Is the new treatment surpassing Osimertinib? This prescription combines chemotherapy and targeted therapies, extending progression-free survival. However, its impact on overall survival remains uncertain. Ongoing research is evaluating its true efficacy.

腫瘤科醫師的生活點滴
臉書facebook：
https://m.facebook.com/profile.php/?id=100063644122566
Instagram：
https://instagram.com/chiaoenpeter?igshid=OGQ5ZDc2ODk2ZA==
加入頻道會員：
https://www.youtube.com/channel/UCBvUlnJq3TpnGtbV6fdnl2A/join
分享會員專屬影片：
https://www.youtube.com/playlist?list=UUMOBvUlnJq3TpnGtbV6fdnl2A